Jaime Bald

1.4k total citations · 1 hit paper
10 papers, 903 citations indexed

About

Jaime Bald is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Jaime Bald has authored 10 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in Jaime Bald's work include Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jaime Bald is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jaime Bald collaborates with scholars based in United States, Belgium and Denmark. Jaime Bald's co-authors include Torben Plesner, A. Kate Sasser, Niels W.C.J. van de Donk, Tahamtan Ahmadi, Tineke Casneuf, Henk M. Lokhorst, Inger S. Nijhof, Jakub Krejcik, Tuna Mutis and Brendan M. Weiss and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jaime Bald

10 papers receiving 895 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

2016 649 citations Jakub Krejcik, Tineke Casneuf et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaime Bald United States	8	639	499	339	258	172	10	903
Jakub Krejcik Denmark	10	795 1.2×	593 1.2×	449 1.3×	322 1.2×	183 1.1×	13	1.1k
Michael S. van der Veer Netherlands	4	731 1.1×	528 1.1×	429 1.3×	268 1.0×	246 1.4×	7	1.0k
Daniëlle C.H. Jacobs Netherlands	4	562 0.9×	514 1.0×	366 1.1×	206 0.8×	298 1.7×	9	951
Thomas G. Martin United States	15	593 0.9×	534 1.1×	446 1.3×	138 0.5×	150 0.9×	79	946
Grégory Ehx Belgium	16	262 0.4×	213 0.4×	270 0.8×	294 1.1×	31 0.2×	39	696
Sandy W. Wong United States	20	583 0.9×	683 1.4×	593 1.7×	164 0.6×	159 0.9×	86	1.1k
Prashant Tembhare India	17	438 0.7×	300 0.6×	233 0.7×	180 0.7×	44 0.3×	97	909
Luis Palomera Spain	14	634 1.0×	421 0.8×	500 1.5×	179 0.7×	40 0.2×	30	903
Tara Masterson United States	16	431 0.7×	349 0.7×	279 0.8×	151 0.6×	181 1.1×	42	663
Jana Hof Germany	15	398 0.6×	253 0.5×	305 0.9×	62 0.2×	14 0.1×	18	999

Countries citing papers authored by Jaime Bald

Since Specialization

Citations

This map shows the geographic impact of Jaime Bald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Bald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Bald more than expected).

Fields of papers citing papers by Jaime Bald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Bald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Bald. The network helps show where Jaime Bald may publish in the future.

Co-authorship network of co-authors of Jaime Bald

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Bald. A scholar is included among the top collaborators of Jaime Bald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Bald. Jaime Bald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Adams, Homer, Frederik Stevenaert, Jakub Krejcik, et al.. (2018). High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action. Cytometry Part A. 95(3). 279–289. 94 indexed citations

2.

Izhak, Liat, Dana E. Cullen, Leopoldo Luistro, et al.. (2017). Abstract 3636: Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models. Cancer Research. 77(13_Supplement). 3636–3636. 7 indexed citations

3.

Adams, Homer, Frederik Stevenaert, Jakub Krejcik, et al.. (2016). High-Parameter Mass Cytometry (CyTOF) Evaluation of Relapsed/Refractory Multiple Myeloma (MM) Pts (Pts) Treated with Daratumumab Supports Immune Modulation As a Novel Mechanism of Action. Blood. 128(22). 4521–4521. 9 indexed citations

4.

Chiu, Christopher, Tineke Casneuf, Amy Axel, et al.. (2016). Daratumumab in Combination with Lenalidomide Plus Dexamethasone Induces Clonality Increase and T-Cell Expansion: Results from a Phase 3 Randomized Study (POLLUX). Blood. 128(22). 4531–4531. 29 indexed citations

5.

McCudden, Christopher R., Amy Axel, Dominique Slaets, et al.. (2016). Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference. Clinical Chemistry and Laboratory Medicine (CCLM). 54(6). 1095–104. 82 indexed citations

6.

Krejcik, Jakub, Tineke Casneuf, Inger S. Nijhof, et al.. (2016). Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood. 128(3). 384–394. 649 indexed citations breakdown →

7.

Casneuf, Tineke, Andrew C. Lysaght, Clare V. LeFave, et al.. (2015). Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy. Blood. 126(23). 1837–1837. 2 indexed citations

8.

McCudden, Christopher R., Amy Axel, Dominique Slaets, et al.. (2015). Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.. Journal of Clinical Oncology. 33(15_suppl). 8590–8590. 16 indexed citations

9.

Krejcik, Jakub, Tineke Casneuf, Inger S. Nijhof, et al.. (2015). Immunomodulatory Effects and Adaptive Immune Response to Daratumumab in Multiple Myeloma. Blood. 126(23). 3037–3037. 8 indexed citations

10.

Bald, Jaime, Kenneth G. Sharp, & Alan G. MacDiarmid. (1974). The isolation and characterization of pentafluorodisilane. Journal of Fluorine Chemistry. 3(3-4). 433–435. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact